ÂÜÀòÂÒÂ×

Johanna Paris currently serves as a Principal Scientist at Sanofi since September 2022, bringing extensive experience in mass spectrometry and bioanalytical processes. Prior to this role, Johanna completed a PhD at the University of Warwick from April 2018 to June 2022, focusing on the detection and fragmentation of post-translational modifications under the guidance of Peter O’Connor and John O’Hara. Previous positions include a Bioanalytical Scientist at UCB, where analysis of antibody therapeutics was conducted, and involvement in the development of mass spectrometry methods for quantifying post-translational modifications. Johanna also gained valuable experience through internships at UCB, Sanofi Pasteur, and a clinical toxicology lab, coupled with academic training, including a Master's degree in Biotechnology from ENSTBB Bordeaux INP.